Literature DB >> 18642127

Collagen-related gene and protein expression changes in the lung in response to chronic hypoxia.

Kristine D Estrada1, Naomi C Chesler.   

Abstract

Collagen accumulation likely contributes to increased vascular and airway impedance in hypoxia-induced pulmonary hypertension (HPH). Collagen exists in multiple subtypes and can accumulate via increased synthesis or decreased degradation. To better understand the individual contributions of fibrillar (FB) and basement membrane (BM) collagen, matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs (TIMPs) to pulmonary vascular and airway remodeling in HPH, we investigated the temporal changes in gene and protein expression in the lungs of mice exposed to hypoxia for 0, 3, 6, 10 and 15 days. The earliest and largest change in gene expression was of type I FB collagen, which was significantly increased over control levels at 6, 10 and 15 days of hypoxia (p < 0.05). Type III FB and type IV BM collagen were increased at 10 and 15 days of hypoxia (p < 0.05); MMP and TIMP gene expression levels were typically higher but sometimes lower than control levels at various time points. Collagen protein content was increased in whole lungs as early as 6 days of hypoxia and increased monotonically with longer exposures. However, neither qualitative nor semi-quantitative analysis of immunohistochemistry demonstrated accumulation of type I FB collagen in compartments of the lung other than large airways, suggesting that other collagen subtypes may be important contributors to collagen protein accumulation. These results provide insight into the patterns of gene and protein expression relevant to collagen accumulation in the lung in response to chronic hypoxia, through which we can develop a better understanding of the time course of changes in matrix biology and biomechanics that occur in HPH.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18642127      PMCID: PMC2718063          DOI: 10.1007/s10237-008-0133-2

Source DB:  PubMed          Journal:  Biomech Model Mechanobiol        ISSN: 1617-7940


  30 in total

1.  cDNA array hybridization after laser-assisted microdissection from nonneoplastic tissue.

Authors:  Ludger Fink; Stephanie Kohlhoff; Maria Magdalena Stein; Jörg Hänze; Norbert Weissmann; Frank Rose; Ercan Akkayagil; Daniel Manz; Friedrich Grimminger; Werner Seeger; Rainer Maria Bohle
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

Review 2.  Pulmonary vascular remodeling: a target for therapeutic intervention in pulmonary hypertension.

Authors:  T K Jeffery; J C Wanstall
Journal:  Pharmacol Ther       Date:  2001-10       Impact factor: 12.310

3.  Gelatinase expression in pulmonary arteries during experimental pulmonary hypertension.

Authors:  E Frisdal; V Gest; A Vieillard-Baron; M Levame; H Lepetit; S Eddahibi; C Lafuma; A Harf; S Adnot; M P Dortho
Journal:  Eur Respir J       Date:  2001-11       Impact factor: 16.671

Review 4.  Pathophysiology and clinical effects of chronic hypoxia.

Authors:  D J Pierson
Journal:  Respir Care       Date:  2000-01       Impact factor: 2.258

5.  BMP type II receptor is required for gastrulation and early development of mouse embryos.

Authors:  H Beppu; M Kawabata; T Hamamoto; A Chytil; O Minowa; T Noda; K Miyazono
Journal:  Dev Biol       Date:  2000-05-01       Impact factor: 3.582

6.  Occurrence and temporal variation in matrix metalloproteinases and their inhibitors during murine secondary palatal morphogenesis.

Authors:  J Morris-Wiman; Y Du; L Brinkley
Journal:  J Craniofac Genet Dev Biol       Date:  1999 Oct-Dec

Review 7.  Small artery remodeling in hypertension.

Authors:  Michael J Mulvany
Journal:  Curr Hypertens Rep       Date:  2002-02       Impact factor: 5.369

8.  Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension.

Authors:  K B Lane; R D Machado; M W Pauciulo; J R Thomson; J A Phillips; J E Loyd; W C Nichols; R C Trembath
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

Review 9.  Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis.

Authors:  H D Intengan; E L Schiffrin
Journal:  Hypertension       Date:  2001-09       Impact factor: 10.190

Review 10.  Clinical perspective of hypoxia-mediated pulmonary hypertension.

Authors:  Ioana R Preston
Journal:  Antioxid Redox Signal       Date:  2007-06       Impact factor: 8.401

View more
  20 in total

1.  Effects of acute Rho kinase inhibition on chronic hypoxia-induced changes in proximal and distal pulmonary arterial structure and function.

Authors:  Rebecca R Vanderpool; Ah Ram Kim; Robert Molthen; Naomi C Chesler
Journal:  J Appl Physiol (1985)       Date:  2010-11-18

2.  Hyperoxia accelerates progression of hepatic fibrosis by up-regulation of transforming growth factor-β expression.

Authors:  Sang Hwa Lee; Sung-Im Do; Hyun-Soo Kim
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

3.  Inhaled combination of sildenafil and rosiglitazone improves pulmonary hemodynamics, cardiac function, and arterial remodeling.

Authors:  Jahidur Rashid; Eva Nozik-Grayck; Ivan F McMurtry; Kurt R Stenmark; Fakhrul Ahsan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-10-11       Impact factor: 5.464

4.  Pulmonary vascular collagen content, not cross-linking, contributes to right ventricular pulsatile afterload and overload in early pulmonary hypertension.

Authors:  Zhijie Wang; David A Schreier; Hinnah Abid; Timothy A Hacker; Naomi C Chesler
Journal:  J Appl Physiol (1985)       Date:  2016-11-17

5.  Alteration of pulmonary artery integrin levels in chronic hypoxia and monocrotaline-induced pulmonary hypertension.

Authors:  Anita Umesh; Omkar Paudel; Yuan-Ning Cao; Allen C Myers; James S K Sham
Journal:  J Vasc Res       Date:  2011-08-10       Impact factor: 1.934

6.  Hypoxia potentiates allergen induction of HIF-1α, chemokines, airway inflammation, TGF-β1, and airway remodeling in a mouse model.

Authors:  Kwang Je Baek; Jae Youn Cho; Peter Rosenthal; Laura E Crotty Alexander; Victor Nizet; David H Broide
Journal:  Clin Immunol       Date:  2013-02-21       Impact factor: 3.969

Review 7.  Role of extracellular matrix in the pathogenesis of pulmonary arterial hypertension.

Authors:  Thenappan Thenappan; Stephen Y Chan; E Kenneth Weir
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-08-24       Impact factor: 4.733

8.  The role of collagen synthesis in ventricular and vascular adaptation to hypoxic pulmonary hypertension.

Authors:  David Schreier; Timothy Hacker; Gouqing Song; Naomi Chesler
Journal:  J Biomech Eng       Date:  2013-02       Impact factor: 2.097

9.  Effects of collagen deposition on passive and active mechanical properties of large pulmonary arteries in hypoxic pulmonary hypertension.

Authors:  Zhijie Wang; Roderic S Lakes; Jens C Eickhoff; Naomi C Chesler
Journal:  Biomech Model Mechanobiol       Date:  2013-02-03

10.  Cellular, pharmacological, and biophysical evaluation of explanted lungs from a patient with sickle cell disease and severe pulmonary arterial hypertension.

Authors:  Natasha M Rogers; Mingyi Yao; John Sembrat; M Patricia George; Heather Knupp; Mark Ross; Maryam Sharifi-Sanjani; Jadranka Milosevic; Claudette St Croix; Revathi Rajkumar; Maria G Frid; Kendall S Hunter; Luciano Mazzaro; Enrico M Novelli; Kurt R Stenmark; Mark T Gladwin; Ferhaan Ahmad; Hunter C Champion; Jeffrey S Isenberg
Journal:  Pulm Circ       Date:  2013-12       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.